REGN vs WGRX
Regeneron Pharmaceuticals Inc (REGN) versus Wellgistics Health, Inc. Common Stock (WGRX) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Wellgistics Health, Inc. Common Stock (WGRX) is a pharmaceutical retailers company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
WGRX does not have a complete income-statement cache yet.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WGRX currently screens at market cap $0.
Not investment advice. Open the REGN and WGRX stock pages for the full models.
Not investment advice.